What does a mixed‑meal test showing normal glucose at 30 minutes with markedly elevated insulin and C‑peptide, followed by hypoglycaemia at 45 minutes with inappropriately high insulin and C‑peptide, indicate?

Post-Bariatric Hyperinsulinemic Hypoglycemia (Late Dumping Syndrome)

These laboratory findings—markedly elevated insulin (3423 pmol/L) and C-peptide (6201 pmol/L) at 30 minutes followed by hypoglycemia (3.4 mmol/L) with persistently elevated insulin (980 pmol/L) and C-peptide (4341 pmol/L) at 45 minutes—are diagnostic of post-bariatric hyperinsulinemic hypoglycemia, also known as late dumping syndrome. 1, 2

Pathophysiology

The pattern described represents the hallmark of post-bariatric hypoglycemia:

• Rapid carbohydrate delivery to the small intestine (after gastric bypass or sleeve gastrectomy) triggers an exaggerated incretin hormone response, particularly GLP-1, which can increase 10-fold above normal levels 2

• This incretin surge causes massive insulin oversecretion—the insulin level of 3423 pmol/L at 30 minutes represents approximately 160 mIU/L, which is grossly excessive for a glucose of 7.4 mmol/L 1, 2

• The hyperinsulinemia then drives a sharp glucose drop within 15-45 minutes, resulting in reactive hypoglycemia 1-3 hours after meals 3, 1, 2

• Inappropriately elevated C-peptide and insulin during hypoglycemia (4341 pmol/L and 980 pmol/L respectively at glucose 3.4 mmol/L) confirms endogenous hyperinsulinism rather than exogenous insulin administration 4, 5, 6

Diagnostic Confirmation

This mixed-meal test result is pathognomonic for post-bariatric hypoglycemia when the following criteria are met:

• Development of hypoglycemia (glucose <3.9 mmol/L, here 3.4 mmol/L) between 30-180 minutes after meal ingestion 4

• C-peptide >0.2-0.3 nmol/L (here 4.3 nmol/L = 4300 pmol/L, vastly elevated) during the hypoglycemic episode confirms endogenous insulin production 4, 5, 7

• The timing (30-45 minutes) can occur earlier than the typical 1-3 hour window, as symptoms may begin as early as 30 minutes post-prandially 1

Key Distinguishing Features

This is NOT insulinoma because:

• Insulinoma causes fasting hypoglycemia, not post-prandial reactive hypoglycemia 1, 4

• The supervised 72-hour fast would be the appropriate test for insulinoma, not a mixed-meal test 4

This is NOT factitious hypoglycemia because:

• Exogenous insulin administration would show suppressed C-peptide (<0.2 nmol/L), not elevated 4, 6

• Sulfonylurea ingestion should be ruled out with urine/plasma screening, though the extreme insulin elevation makes this less likely 4

Clinical Context Required

Critical history to obtain:

• Prior bariatric surgery (Roux-en-Y gastric bypass, sleeve gastrectomy, or other gastric procedures) is the most common cause, affecting up to 34% of post-surgical patients 3, 1, 2

• Timing of surgery: symptoms typically present >1 year post-operatively, distinguishing this from early dumping syndrome which occurs within 10-30 minutes and improves over time 3, 1, 2

• Other upper GI surgeries (esophagectomy, vagotomy with pyloroplasty) can also cause this pattern 1

Management Algorithm

First-Line: Strict Dietary Modification 3, 1, 2

• Eliminate rapidly absorbable carbohydrates completely (sugars, refined grains, high-glycemic foods) 1, 2

• Consume high-fiber, protein-rich foods with healthy fats 1, 2

• Eat 4-6 small meals rather than 3 large meals 1

• Separate fluids from solids by at least 30 minutes to slow gastric emptying 1

• Refer to a dietitian experienced in post-bariatric hypoglycemia 3, 2

Second-Line: Continuous Glucose Monitoring 3, 2

• Implement real-time CGM to detect dropping glucose before severe hypoglycemia and hypoglycemia unawareness develop 3, 2

Third-Line: Pharmacologic Therapy (if dietary measures insufficient) 3, 1, 2

1. Acarbose (α-glucosidase inhibitor): specifically indicated for late dumping, slows carbohydrate absorption and attenuates hyperinsulinemic response 3, 1, 2

2. Diazoxide: reduces insulin secretion, may decrease hypoglycemic events by 50% at doses ~170 mg/day 2

3. Somatostatin analogues (octreotide): most effective medical therapy for refractory cases, though costly with significant side effects 1, 2

4. Calcium channel blockers (nifedipine, verapamil): partial response in ~50% of patients 2

Fourth-Line: Surgical Intervention (severe, refractory cases) 2, 8

• Gastric bypass reversal or gastric pouch restriction: higher success rates than pancreatic resection 2, 8

• Avoid pancreatic resection: 90% experience recurrent symptoms, only 48% achieve moderate success 2

Critical Pitfalls to Avoid

• Do not use oral glucose tolerance test (OGTT) for diagnosis—it has low accuracy and high false-positive rates in asymptomatic individuals 4

• Do not assume insulinoma based solely on elevated insulin/C-peptide during hypoglycemia—the post-prandial timing is the key distinguishing feature 1, 4

• Screen for psychological complications: patients are at increased risk for depression, anxiety, substance abuse, and suicidal ideation 3, 2

• Monitor for nutritional deficiencies: ensure lifelong vitamin/mineral supplementation 3

• Rule out other post-surgical complications (marginal ulcer, anastomotic stenosis, internal herniation, gallstones) before attributing all symptoms to hypoglycemia 4

Quality of Life Impact

Severe post-bariatric hypoglycemia can cause:

• Neuroglycopenic symptoms: impaired cognition, loss of consciousness, seizures 3, 2

• Autonomic symptoms: sweating, tremor, tachycardia, palpitations 3, 2

• Food avoidance leading to weight loss up to 30% of preoperative weight 2

• Substantial reduction in quality of life with anxiety and emotional distress 2